Amneal Pharmaceuticals, Inc. Class A Common Stock
$18.28
$0.20 (+1.11%)
$18.12Day Range$19.18
Key Statistics
Market Cap
$6.37B
Shares Outstanding
348.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 7, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$18.56
Day High
$19.18
Day Low
$18.12
Volume
2.82M
VWAP
$18.41
Prev Close
$18.08
Transactions
--
Acc. Volume
--
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
PHARMACEUTICAL PREPARATIONSSIC 28348,500 employees(908) 947-3120IPO May 7, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001723128
- Composite FIGI
- BBG00462PGG0
- Share Class FIGI
- BBG00462PGH9
- Ticker Root
- AMRX
- SIC Code
- 2834
About Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) closed the 2026-09-17 session at $18.28, up 1.11% versus the previous close (+0.20). The stock opened at $18.56 and traded between $18.12 and $19.18 during that session. Session trading volume was 2.8M shares. The volume-weighted average price (VWAP) is $18.41.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Amneal Pharmaceuticals, Inc. Class A Common Stock has a market capitalization of $6.37 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. AMRX is listed on the XNAS exchange. The company employs approximately 8,500 people. The recorded listing date is 2018-05-07.
On this page you can find market AMRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.